Some antidepressants could potentially be used to treat a wide range of diseases caused by bacteria living within cells, according to work by researchers in the Virginia Commonwealth University School of Medicine and collaborators at other institutions.
Research published in the April print edition of the journal Life Science Alliance, shows that antidepressant drugs called FIASMAs, including desipramine, amitriptyline, and nortriptyline, halt the growth or kill four different intracellular bacterial pathogens in tissue cell culture and animal models.
“Antibiotic options for diseases caused by intracellular bacteria are limited because many of these drugs cannot penetrate our cell membranes. In essence, the bacteria are protected,” said Jason Carlyon, Ph.D., leader of the study and professor in the VCU Department of Microbiology and Immunology.
Tetracycline antibiotics are most commonly prescribed to treat intracellular bacterial infections because they can cross cell membranes to reach the microbes. However, tetracyclines can cause allergic reactions in some patients and physicians advise against their use by pregnant women and children due to undesirable side effects. Additionally, antibiotic resistance in some intracellular bacteria has been reported.
“It would be highly beneficial to have a class of drugs to treat such diseases in patients for whom tetracyclines are contraindicated,” Carlyon said. “These drugs could provide an alternative to antibiotics or even be used in conjunction with them as an augmentation approach to treat infections that typically require prolonged courses of antibiotic therapy, such as those caused by Chlamydia pneumoniae and Coxiella burnetti.”
The team of researchers from VCU, Indiana University Medical Center, University of Nebraska Medical Center, University of Arkansas for Medical Sciences, and the University of South Florida, including Carlyon and lead author Chelsea Cockburn, an M.D.-Ph.D. candidate, are the first to investigate the mechanisms by which FIASMAs target multiple intracellular bacteria in detail.
The scientists tested FIASMA susceptibility for four bacterial species that cause human granulocytic anaplasmosis, a tick-borne disease that attacks white blood cells called neutrophils and can be fatal to immune compromised individuals; Q fever, a debilitating pneumonic disease; and two chlamydia infections.
FIASMAs ultimately disrupt how cholesterol, a key nutrient utilized by many intracellular pathogens, traffics inside cells to alter bacterial access to the lipid. The researchers first proved FIASMA treatment efficacy by halting anaplasmosis in both tissue culture and mice. Next, they extended their observations to demonstrate that FIASMA treatment killed the Q fever agent,Coxiella burnetii, and partially inhibited chlamydial infections in cell culture.
“Since FIASMAs influence cholesterol trafficking in the cell and cholesterol plays a role in so many facets of our biology, they have been used to treat a wide variety of conditions and diseases,” Carlyon said.
He added that the effect of FIASMAs on intracellular cholesterol ultimately bypasses the need to directly target the bacteria.
“What is so exciting about this study is that the class of drugs we evaluated targets an enzyme in our cells regulating cholesterol, not the bacteria,” Carlyon said. “I do not envision the pathogens being able to develop resistance to this treatment because it is targeting a host pathway that they very much need to grow and survive inside of the body.”
Learn more: Certain antidepressants could provide a frontline treatment for multiple infectious diseases, testing shows
The Latest on: Alternative to antibiotics
[google_news title=”” keyword=”alternative to antibiotics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Alternative to antibiotics
- Fred Allendorf: Science and Nature: Evolution of antibiotic resistance in bacteriaon May 7, 2024 at 5:45 am
Approximately 8 million people die annually around the world from infectious diseases caused by bacteria. Bacterial diseases have been the major cause of human mortality throughout history. For ...
- Trial data support non-antibiotic treatment for bacterial vaginosison May 3, 2024 at 11:55 am
The trial investigated the efficacy of the broad-spectrum antiseptic dequalinium chloride for treating bacterial vaginosis (BV), which affects an estimated 25% of reproductive-age women and has a high ...
- Antibacterial Substance From Bacteria Could Provide Alternative to Antibioticson April 30, 2024 at 1:38 am
Many bacteria produce substances to gain an advantage over competitors in their highly competitive natural environment. Researchers at the University Hospital Bonn (UKB), the University of Bonn and ...
- Lantibiotics a Possible Alternative to Antibioticson April 30, 2024 at 12:39 am
We preselected all newsletters you had before unsubscribing.
- Antibiotic Alternative Produced by Gram-Positive Bacteriaon April 29, 2024 at 10:15 pm
Due to increasing antibiotic resistance in pathogens causing infections, the development of new antibacterial substances is needed. Scientists are testing out a new group of substances produced by ...
- Antibiotic Alternative Produced by Gram-Positive Bacteriaon April 29, 2024 at 5:00 pm
Due to increasing antibiotic resistance in pathogens causing infections, the development of new antibacterial substances is needed. Scientists are testing out a new group of substances produced by ...
- Possible alternative to antibiotics produced by bacteriaon April 29, 2024 at 3:21 pm
Many bacteria produce substances to gain an advantage over competitors in their highly competitive natural environment. Researchers have discovered a new so-called lantibiotic, namely epilancin A37.
- Possible alternative to antibiotics produced by bacteriaon April 29, 2024 at 9:50 am
Their results have now been published in the renowned ISME Journal. Due to increasing antibiotic resistance in pathogens causing infections, the development of new antibacterial substances is ...
- Antimicrobial resistance projected to kill 10 million people each yearon April 28, 2024 at 10:45 am
Dr. James Gill addresses antimicrobial resistance and its accelerating crisis, emphasizing the need for patient education.
- No Antibiotics Needed – Revolutionary Chronic Wound Treatment Could Help Millionson April 28, 2024 at 1:29 am
An international team of scientists has developed a new treatment for chronic wounds that uses ionized gas to activate a wound dressing, without the need for antibiotics. The treatment involves the pl ...
via Bing News